Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Digital Cognitive Training in Older Adults

11 de novembro de 2026 atualizado por: Jihye Jung

Effect of a Physical Acticity-Integrated Digital Cognitive Training Program on Cognitive Function and Physical Performance in Community-Dwelling Older Adults

The purpose of this clinical study is to evaluate the effects of a digital cognitive training program combined with physical activity on the cognitive and physical functions of community-dwelling older adults. For older adults, maintaining both mental and physical health is essential for overall well-being. This study hypothesizes that combining tablet-based brain exercises with short, physical activities will help improve participants' memory, thinking skills, and physical abilities, such as balance and walking.

Researchers aim to enroll approximately 35 community-dwelling older adults who are 65 years of age or older and capable of walking. Participants will be randomly assigned to one of two groups:

  1. Standard Intervention Group: Participants will attend a 50-minute session once a week for 10 weeks. During each session, they will use a tablet device for cognitive training focused on memory, attention, and executive functions. This training will be paused three times per session for about 3 minutes each to perform low-intensity, physical activities to music.
  2. Extended Intervention Group: Participants will participate in the same 10-week digital cognitive training and physical activity program as the standard group. In addition, they will receive additional home-based cognitive activities to complete once a week.

To measure the effectiveness of the program, researchers will assess all participants before the program starts and after the 10-week program ends. Assessments will evaluate cognitive function, including memory and attention, as well as physical functions, such as grip strength, leg strength, balance, walking speed, and muscle mass.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

35

Estágio

  • Não aplicável

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

65 anos e mais velhos (Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Community-dwelling older adults aged 65 years or older.
  • Able to understand the purpose of the study and voluntarily consent to participate.
  • Cognitively intact or presenting with mild subjective memory complaints without a diagnosis of dementia (e.g., MoCA score ≥ 23 or MMSE score ≥ 24).
  • Able to walk independently without assistance (with or without assistive devices).
  • Able to understand instructions and perform cognitive and physical training programs using digital devices.

Exclusion Criteria:

  • Diagnosis of dementia or severe cognitive impairment.
  • Severe visual or hearing impairment that interferes with participating in digital training or assessment.
  • Acute or chronic neurological/musculoskeletal disorders that limit physical training (e.g., recent stroke, severe osteoarthritis).
  • History of severe cardiovascular disease or unmanaged hypertension/diabetes.
  • Current participation in other interventional clinical trials or similar cognitive/physical training programs.
  • Inability to follow study instructions due to severe psychiatric illness or communication difficulties.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: Standard Intervention Group

Participants will receive a 50-minute session consisting of tablet-based digital cognitive training combined with physical activities once a week for 10 weeks.

A 10-week program where participants attend a 50-minute session once a week. Each session involves tablet-based digital cognitive training (focusing on memory, attention, and executive functions) combined with three 3-minute bouts of low-intensity, physical activities.

Experimental: Extended Intervention Group

Participants will receive the same 10-week program as the Standard Intervention Group (tablet-based digital cognitive training and seated physical activities). In addition, they will receive home-based cognitive activities to complete once a week.

A 10-week program combining a once-weekly 50-minute center-based session (tablet-based cognitive training and seated physical activities) with additional home-based cognitive activities to be completed once a week.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
The Korean Version of Montreal Cognitive Assessment (MoCA-K)
Prazo: Baseline and 10 weeks

Cognitive function will be assessed using the Korean version of the Montreal Cognitive Assessment (MoCA-K). Total scores range from 0 to 30, where higher scores indicate better cognitive performance.

Baseline and 10 weeks

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
The Short Physical Performance Battery (SPPB).
Prazo: Baseline and 10 weeks

Overall physical performance will be assessed using the Short Physical Performance Battery (SPPB). The SPPB evaluates lower extremity function through three components: standing balance, gait speed, and a 5-repetition chair stand test. Each component is scored from 0 to 4, yielding a total score ranging from 0 to 12. Higher scores indicate better physical function.

Baseline and 10 weeks
Change in Grip Strength
Prazo: Baseline and 10 weeks

Handgrip strength will be measured using a hand dynamometer. Results are recorded in kilograms (kg), where higher values indicate greater upper body muscle strength.

Baseline and 10 weeks
Change in Lower Extremity Strength
Prazo: Baseline and 10 weeks

Lower body strength will be assessed using the Five-times Sit-to-Stand test. Scores indicate the seconds of stands completed in 5 times, where a higher number indicates better lower extremity strength.

Baseline and 10 weeks
Change in Dynamic Balance
Prazo: Baseline and 10 weeks

Dynamic balance will be assessed using the Timed Up and Go (TUG) test. Results are measured in seconds, where a lower time indicates better mobility and dynamic balance.

Baseline and 10 weeks
Change in Static Balance
Prazo: Baseline and 10 weeks

Static balance will be assessed using the Balancia software by measuring COP sway path length under the eyes open and closed condition. Results are recorded in centimeters (cm), where lower values indicate better postural stability.

Baseline and 10 weeks
Change in Gait velocity
Prazo: Baseline and 10 weeks

Gait velocity will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters per second (cm/s), where higher values indicate better walking performance.

Baseline and 10 weeks
Change in Gait cadence
Prazo: Baseline and 10 weeks

Gait cadence will be assessed using the GAITRite electronic walkway system. Results are measured in steps per minute (steps/min), where higher values indicate better gait rhythm and coordination.

Baseline and 10 weeks
Change in Step Length
Prazo: Baseline and 10 weeks

Step length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better gait efficiency.

Baseline and 10 weeks
Change in Stride Length
Prazo: Baseline and 10 weeks

Stride length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better mobility.

Baseline and 10 weeks
Change in Skeletal Muscle Mass Index (SMI)
Prazo: Baseline and 10 weeks

Skeletal Muscle Mass Index (SMI) will be assessed using a Bioelectrical Impedance Analysis (BIA) device (InBody BWA). SMI is reported in kg/m², where higher values indicate greater skeletal muscle mass.

Baseline and 10 weeks
Change in Subjective Memory Complaints (SMCQ-K)
Prazo: Baseline and 10 weeks

Subjective memory complaints will be assessed using the Subjective Memory Complaints Questionnaire (SMCQ-K). Scores range from 0 to 14, where higher scores indicate a higher level of subjective memory impairment.

Baseline and 10 weeks
Change in Pain Intensity (NPRS)
Prazo: Baseline and 10 weeks

Pain intensity will be measured using the Numeric Pain Rating Scale (NPRS) for participants reporting pain. Scores range from 0 (no pain) to 10 (worst possible pain), where lower scores indicate reduced pain intensity.

Baseline and 10 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de novembro de 2026

Conclusão Primária (Estimado)

1 de fevereiro de 2027

Conclusão do estudo (Estimado)

1 de fevereiro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

5 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de novembro de 2026

Primeira postagem (Real)

17 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • SYU 2026-09-027-002

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever